Page last updated: 2024-11-05

bpmc

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BPMC: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fenobucarb : A carbamate ester obtained by the formal condensation of 2-sec-butylphenol with methylcarbamic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID19588
CHEMBL ID226650
CHEBI ID34304
SCHEMBL ID73674
MeSH IDM0071621

Synonyms (62)

Synonym
carbamic acid, methyl-, o-sec-butylphenyl ester
phenol, 2-(1-methylpropyl)-, methylcarbamate
fenobucarb [bsi:iso]
bassa
fenobcarb
ai3-27212
2-butylphenyl methylcarbamate
carvil
osbac
hopcin
baycarb
geocarb 50ec
bay 41637
bayer 41367c
einecs 223-188-8
brn 2052332
o-sec-butylphenyl methylcarbamate
2-sek.butylfenylester kyseliny methylkarbaminove [czech]
barizon
bayer 41637
CHEBI:34304 ,
2-sec-butylphenyl methylcarbamate
fenobucarb
bpmc
2-sec-butylphenyl n-methylcarbamate
methylcarbamic acid o-sec-butylphenyl ester
3766-81-2
2-(butan-2-yl)phenyl methylcarbamate
2-(1-methylpropyl)phenyl methylcarbamate
CHEMBL226650
(2-butan-2-ylphenyl) n-methylcarbamate
dirfujhnvnobmy-uhfffaoysa-
inchi=1/c12h17no2/c1-4-9(2)10-7-5-6-8-11(10)15-12(14)13-3/h5-9h,4h2,1-3h3,(h,13,14)
phenol, 2-(1-methylpropyl)-, 1-(n-methylcarbamate)
5ms2p7m0cf ,
o-sec-butylphenyl n-methylcarbamate
2-sek.butylfenylester kyseliny methylkarbaminove
unii-5ms2p7m0cf
2-sec-butylphenyl-n-methylcarbamate
baycarb (tm)
AKOS015960925
FT-0603649
bay-41637
fenobucarb [iso]
(+/-)-fenobucarb
fenobucarb, (+/-)-
SCHEMBL73674
DTXSID4058077
2-sec butylphenyl n-methylcarbamate
2-sec. butylphenyl n-methylcarbamate
2-sec-butylphenyl methylcarbamate #
2-(sec-butyl)phenyl methylcarbamate
mfcd00053081
methyl-carbamic acid 2-sec-butyl-phenyl ester
fenobucarb, pestanal(r), analytical standard
fenobucarb 10 microg/ml in cyclohexane
Q3268119
AS-76198
CS-0012849
HY-B0835
2-(butan-2-yl)phenyl n-methylcarbamate
SY110156

Research Excerpts

Toxicity

Fenitrothion of oral subtoxic dose (100 mg/kg; 4 hr pretreatment) decreased acute oral LD50 of BPMC from 360 to 66mg/kg in male mice. Simultaneous administration of B PMC and either one of the thiophosphates (fenthion, its sulfoxide and sulfone) in a dose of 1/40 of its LD50 resulted in a 2- to 3-fold potentiation.

ExcerptReferenceRelevance
"Malathion-induced marked potentiation of BPMC toxicity (about fivefold) was analyzed by measuring LD50 as an index of acute toxicity."( Contribution of monoaminergic nervous system in potentiation of 2-sec-butylphenyl N-methylcarbamate (BPMC) toxicity by malathion in male mice.
Shirasu, Y; Takahashi, H; Tanaka, J; Tsuda, S, 1987
)
0.75
" Simultaneous administration of BPMC and either one of the thiophosphates (fenthion, its sulfoxide and sulfone) in a dose of 1/40 of its LD50 resulted in a 2- to 3-fold potentiation."( Mechanism of potentiation of BPMC toxicity by fenthion pretreatment in mice.
Miyaoka, T; Shirasu, Y; Tsuda, S, 1986
)
0.85
"Fenitrothion of oral subtoxic dose (100 mg/kg; 4 hr pretreatment) decreased acute oral LD50 of BPMC from 360 to 66 mg/kg in male mice."( Potentiated toxicity of 2-sec-butylphenyl methylcarbamate (BPMC) by O,O-dimethyl O-(3-methyl-4-nitrophenyl)phosphorothioate (fenitrothion) in mice; relationship between acute toxicity and metabolism of BPMC.
Miyaoka, T; Shirasu, Y; Takahashi, H; Tsuda, S, 1984
)
0.73
"4% of the po LD50 daily) did not show toxic symptoms except for a slight decrease in body weight."( Pharmacokinetic analysis of increased toxicity of 2-sec-butylphenyl methylcarbamate (BPMC) by fenitrothion pretreatment in mice.
Iwasaki, M; Miyaoka, T; Shirasu, Y; Tsuda, S, 1984
)
0.49
" These results indicate that BPMC is highly toxic to zebrafish and that BPMC induces zebrafish developmental neurotoxicity through pathways involved in inflammation, oxidative stress, degeneration and apoptosis."( Fenobucarb-induced developmental neurotoxicity and mechanisms in zebrafish.
Dai, MZ; Huang, YF; Li, CQ; Li, P; Wu, YY; Xia, B; Yang, H; Zhu, XY, 2020
)
0.85

Bioavailability

ExcerptReferenceRelevance
" To show the importance of physicochemical properties, the classic QSAR and CoMFA of neonicotinoids and prediction of bioavailability of pesticides in terms of membrane permeability in comparison with drugs are described."( Importance of physicochemical properties for the design of new pesticides.
Akamatsu, M, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
herbicideA substance used to destroy plant pests.
insecticideStrictly, a substance intended to kill members of the class Insecta. In common usage, any substance used for preventing, destroying, repelling or controlling insects.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1091956Apparent hydrophobicity, log D of the compound in Octanol-buffer2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Importance of physicochemical properties for the design of new pesticides.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288185Permeability coefficient through artificial membrane in presence of stirred water layer2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1091958Hydrophobicity, log P of the compound in octanol-water by shaking-flask method2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Importance of physicochemical properties for the design of new pesticides.
AID1091955Dissociation constant, pKa of the compound at pH 7.32011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Importance of physicochemical properties for the design of new pesticides.
AID288191Membrane retention in permeability experiment with artificial membrane2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1091957Apparent permeability of the compound by PAMPA2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Importance of physicochemical properties for the design of new pesticides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (25.00)18.7374
1990's3 (6.25)18.2507
2000's13 (27.08)29.6817
2010's15 (31.25)24.3611
2020's5 (10.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 68.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index68.41 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index112.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (68.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.04%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (97.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]